# Livobot

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/livobot

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.livobot.com
- Latest round: Angel (Aug 1, 2022)
- Investors on record: 3

## About

Founded in 2021 and based in Beijing, China, Livobot is a manufacturing company that focuses on the research and development of medical automation equipment. It was recognized as the National High-tech Enterprise. The company has a R&D base in the Life Science Park in Changping District. Dong Wang, the founder of the company, graduated from Tsinghua University, used to work in Boao Biological Group. The company has applied for more than 50 independent intellectual property rights. As of December 2023, the company has a cumulative contract value of CNY 60 million. In May 2024, Livobot closed a pre-series A+ funding.

The company mainly engages in the research and development of medical automation equipment. It has independently developed more than 10 products. Its products include sequencing platform automation equipment, mass spectrometry platform automation equipment, and universal liquid workstation, etc. Its ultra-micro-liquid precision manipulation life science tool platforms adopt precision droplet generation and pipetting technologies. Products can be used in sequencing, mass spectrometry, synthetic biology and drug discovery, and other fields.

The company generates revenue by selling automated and intelligent laboratory equipment and life sciences equipment.

The company will use the pre-series A+ funding for new product development, marketing and construction of a production base.

## Funding rounds

- Angel, Aug 1, 2022 — Changkejin  Investment
- Angel, Jan 10, 2022 — Tsinghua Innovation Ventures, Global Healthcare Innovation Center

## Investors

- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Angel
- Global Healthcare Innovation Center — Angel
- Changkejin  Investment — Angel